Direct Answer
31 SEC filers are classified under the Standard Industrial Classification codes that describe the hearing devices industry, and their latest annual reports show $74.6 billion of combined revenue and a median operating margin of -29.1%. Investors should still evaluate its revenue model, industry-specific KPIs, valuation framework and the risks that can change the group's economics.
Industry Overview
Hearing device makers produce hearing aids and cochlear implants sold through audiologists, retail chains and increasingly direct to consumers. Growth follows aging and acceptance, and over-the-counter options are changing price points. The first numbers to compare across companies here are unit volume and average selling price, gross margin and share of retail channels.
Key Industry Metrics
- Unit volume and average selling price: Number of devices sold and the average price. Volume reflects demand, while price shifts with technology tier and over-the-counter competition.
- Gross margin: Share of sales left after product cost. Premium devices earn more, so cheaper over-the-counter alternatives may weigh on margin.
- Share of retail channels: Portion of sales through audiologists, retail chains and direct-to-consumer. Channel ownership affects bargaining power and price, so shifts matter.
- Over-the-counter exposure: Share of sales in the self-fitted category sold without a professional. It shows how much of the business faces lower price points and broader competition.
- Technology launches: New product generations adding features such as connectivity. Launches refresh the product line and support pricing, but depend on audiologist and consumer uptake.
Primary Macro Drivers
- Aging population: Hearing loss rises with age, so a growing older population expands the pool of potential users, which supports unit volume over time.
- Reimbursement and coverage: Coverage by insurers or government programs reduces what patients pay, which can lift unit volume and mix of higher-priced devices.
- Over-the-counter category growth: Lower-priced devices sold without a prescription draw in people who had not bought before, which grows the market while pressuring average selling price.
- Technology such as connectivity: Better connectivity and noise processing support higher-priced models and upgrades, which supports average selling price and gross margin.
Major Risks
- Price competition from over-the-counter devices: Low-cost consumer devices can pull buyers from prescription hearing aids and push prices down; watch average selling price and unit volume.
- Retail channel changes: A shift of sales toward large retailers or direct sales can change pricing power and mix; watch share by channel and gross margin.
- Regulatory change: Rules on sales channels, labeling and who may dispense can change how devices reach buyers; watch regulatory updates.
- Consumer demand: Hearing aids are often paid out of pocket, so consumer budgets affect unit volume; watch unit volume and average selling price.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Mixed |
| Capital Intensity | Medium |
| Regulatory Intensity | Medium |
| Industry Maturity | Mature |
| Geographic Importance | U.S. / Global |
Hearing Devices Filers in the SEC Record
31 companies with annual reports in the dataset are classified by the SEC in the Standard Industrial Classification codes 3842, 3845. Their latest fiscal years end between 2025 and 2026, and together they reported $74.6 billion of revenue. Median revenue growth over the prior year was 8.4%. Median operating margin was -29.1% and median net margin -30.3%. Median total liabilities were 45% of total assets, and 12 of 31 reported a profit in their latest year.
| Company | Revenue | Growth | Operating margin | Net margin | Year |
|---|---|---|---|---|---|
| Medtronic Plc | $36.4 billion | 8.4% | 17.8% | 0.0% | FY 2026 |
| Intuitive Surgical Inc | $10.1 billion | 20.5% | 29.3% | 28.4% | FY 2025 |
| Zimmer Biomet Holdings, Inc. | $8.2 billion | 7.2% | 13.3% | 8.6% | FY 2025 |
| Edwards Lifesciences Corp | $6.1 billion | 11.5% | 20.8% | 17.7% | FY 2025 |
| Steris Plc | $5.9 billion | 8.7% | 18.6% | 13.2% | FY 2026 |
| Align Technology Inc | $4.0 billion | 0.9% | 13.5% | 10.2% | FY 2025 |
| Msa Safety Inc | $1.9 billion | 3.7% | 19.8% | 14.9% | FY 2025 |
| Cadre Holdings, Inc. | $610 million | 7.5% | 11.0% | 7.2% | FY 2025 |
The 8 largest of 31 by revenue. Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. A company's SIC code reflects its main business as the SEC records it, so it can differ from how an index provider or analyst classifies the company, and a diversified group appears under only one code.
Where to Go Next
The Hearing Devices guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- Home Health
- Health Care Technology
- Hospice
- Health Care Providers & Services
- Hospital Consumables
- Health Care Payments Technology
- Hospitals
- Health Care Equipment & Supplies
Put it to work
Frequently Asked Questions
What are the main KPIs for the Hearing Devices industry?
Key performance indicators for the Hearing Devices industry include: Unit volume and average selling price, Gross margin, Share of retail channels, Over-the-counter exposure, Technology launches. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Hearing Devices industry?
The Hearing Devices industry exhibits mixed cyclicality characteristics. Some segments move with the broader economy while others maintain more stable demand, making stock selection within the group particularly important.
What are the biggest risks in the Hearing Devices industry?
The primary risks for Hearing Devices companies include: Price competition from over-the-counter devices, Retail channel changes, Regulatory change, Consumer demand. Investors should assess each company's exposure to these factors and its track record of navigating them.